RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Australia’s TGA Proposes Major Update of 2001 Labeling Regulations

Australia’s TGA Proposes Major Update of 2001 Labeling Regulations

Posted 25 August 2014 | By Louise Zornoza

Australia’s TGA Proposes Major Update of 2001 Labeling Regulations

This content is provided by RegLink News, publishers of e-weekly global regulatory news. RegLink offers a 30-day free trial and 15% discount on Global Update subscriptions to RAPS members.

 

Australia’s Therapeutic Goods Administration (TGA) is seeking comments on multiple proposals for the first major revision of its 2001 Drug Labeling Regulations.

The regulations are intended to address safety risks posed by issues such as:

  • The difficulty of finding information about a medicine's active ingredient
  • The use of a single brand name across a range of products (i.e. brand extensions)
  • Medicine names that look alike and sound alike, which can lead to use of the incorrect medicine
  • Medicine containers and packaging which appear similar to that of another medicine
  • Lack of a standardized format for information included on medicines labels and packaging
  • Dispensing stickers that cover up important information

TGA is calling for public comment on revisions contained in the following documents:

 The closing date for comments is 7 October 2014.

 

© 2022 Regulatory Affairs Professionals Society.